
A 66-year-old patient with metastatic renal clear cell carcinoma, developed palpable purpura during systemic treatment with different tyrosine kinase inhibitors (TKI).
Medicine (General), R5-920, Vasculitis, Leukocytoclastic, Cutaneous/chemically induced, R, Medicine, Protein Kinase Inhibitors/adverse effects
Medicine (General), R5-920, Vasculitis, Leukocytoclastic, Cutaneous/chemically induced, R, Medicine, Protein Kinase Inhibitors/adverse effects
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
